Blood-borne disease

From Wikipedia, the free encyclopedia
  (Redirected from Blood borne)
Jump to: navigation, search
Blood-borne disease
Classification and external resources
ICD-10 Xxx.x
ICD-9-CM xxx

A blood-borne disease is a disease that can be spread through contamination by blood and other body fluids. Bloodborne pathogens are microorganisms such as viruses or bacteria. The most common examples are HIV, hepatitis B and viral hemorrhagic fevers.

Diseases that are not usually transmitted directly by blood contact, but rather by insect or other vector, are more usefully classified as vector-borne disease, even though the causative agent can be found in blood. Vector-borne diseases include West Nile virus and malaria.

Many blood-borne diseases can also be contracted by other means, including high-risk sexual behavior or intravenous drug use. These diseases have also been identified in sports medicine.[1]

Since it is difficult to determine what pathogens any given sample of blood contains, and some blood-borne diseases are lethal, standard medical practice regards all blood (and any body fluid) as potentially infectious. Blood and Body Fluid precautions are a type of infection control practice that seeks to minimize this sort of disease transmission.


Occupational Exposure to Blood-borne disease[edit]

Blood poses the greatest threat to health in a laboratory or clinical setting due to needlestick injuries (e.g., lack of proper needle disposal techniques and/or safety syringes). These risks are greatest among healthcare workers, including: nurses, surgeons, laboratory assistants, doctors, phlebotomists, and laboratory technicians. [2] These roles often require the use of syringes for blood draws or to administer medications.

There are 26 different viruses that have been shown to present in healthcare workers as a result of occupational exposure.[3] The most common blood borne diseases are are hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV).[4] Exposure is possible through blood of an infected patient splashing onto mucous membranes, but the greatest exposure risk was shown to occur during percutaneous injections performed for vascular access. These include blood draws, as well as catheter placement, as both typically use hollow bore needles.[5] Preventative measures for occupational exposure include standard precautions (hand washing, sharp disposal containers), as well as additional education and preventative measures. Advancements in the design of safety engineered devices have played a significant role in decreasing rates of occupational exposure to blood-borne disease.[6] According to the Massachusetts Sharps Injury Surveillance System, needle devices without safety features accounted for 53% of the 2010 reported sharps injuries.[7] Safer sharps devices now have engineering controls, such as a protective shield over the needle, and sharps containers that have helped to decrease this statistic. These safer alternatives are highly effective in substantially reducing injuries. For instance, almost 83% of injuries from hollow bore needles can be prevented with the use of safer sharps devices. [8]

Blood Transfusions[edit]

Blood for blood transfusion is screened for many blood-borne diseases. Additionally, a technique that uses a combination of riboflavin and UV light to inhibit the replication of these pathogens by altering their nucleic acids can be used to treat blood components prior to their transfusion, and can reduce the risk of disease transmission.[9][10][11]

A technology using the synthetic psoralen, amotosalen HCl, and UVA light (320–400 nm) has been implemented in European blood centers for the treatment of platelet and plasma components to prevent transmission of blood-borne diseases caused by bacteria, viruses and protozoa.[12][13]

Needle Exchange Programs[edit]

Needle exchange programs (NEPs) are an attempt to reduce the spread of blood-borne diseases between intravenous drug users. They often also provide addiction counseling services, infectious disease testing, and in some cases mental health care and/or other case management. NEPs acquired their name as they were initially places where intravenous (IV) illicit substance users were provided with clean, unused needles in exchange for their used needles. This allows for proper disposal of the needles.[14] Empirical studies confirm the benefits of NEPs.[15] NEPs can affect behaviors that result in the transmission of HIV. These behaviors include decreased sharing of used syringes, which reduces contaminated syringes from circulation and replaces them with sterile ones, among other risk reductions.

References[edit]

  1. ^ Jason J. Pirozzolo; Donald C. LeMay (July 2007). "Blood-Borne Infections". Clinics.com. p. Volume 26, Issue 3 , 425–431. Retrieved February 23, 2014. 
  2. ^ S. Deuffic-Burbana, E. Delarocque-Astagneauc, D. Abitebould, E. Bouvetd, Y. Yazdanpanah Blood-borne viruses in healthcare workers: Prevention and management. Journal of Clinical Virology 52(2011) 4-10
  3. ^ Massachusetts Department of Public Health Occupational Health Surveillance Program. (2010) Sharps Injuries among Hospital Workers in Massachusetts, 2010: Findings from the Massachusetts Sharps Injury Surveillance System.
  4. ^ Annette Prüss-Üstün, Elisabetta Rapiti, and Yvan Hutin Estimation of the Global Burden of Disease Attributable to Contaminated Sharps Injuries Among Health-Care Workers. American Journal of Industrial Medicine 48:482–490 (2005)
  5. ^ S. Deuffic-Burbana, E. Delarocque-Astagneauc, D. Abitebould, E. Bouvetd, Y. Yazdanpanah Blood-borne viruses in healthcare workers: Prevention and management. Journal of Clinical Virology 52(2011) 4-10
  6. ^ Annette Prüss-Üstün, Elisabetta Rapiti, and Yvan Hutin Estimation of the Global Burden of Disease Attributable to Contaminated Sharps Injuries Among Health-Care Workers. American Journal of Industrial Medicine 48:482–490 (2005)
  7. ^ Patrick, Deval (March 2012). Governor (PDF). Boston, MA: Massachusetts Department of Public Health. pp. 1–24. 
  8. ^ Centers for Disease Control and Prevention. "Stop Sticks Campaign". The National Institute for Occupational Safety and Health. Retrieved October 18, 2017.   This article incorporates text from this source, which is in the public domain.
  9. ^ Goodrich RP, et al., “Arkk Laboratory Comparison of Pathogen Reduction Technology Treatment and Culture of Platelet Products for Addressing Bacterial Contamination Concerns.” Transfusion 2009;49 : 1205–1216.
  10. ^ Ruane PH, et al., “Photochemical Inactivation of Selected Viruses and Bacteria in Platelet Concentrates Using Riboflavin and Light.” Transfusion 2004; 44: 877-885.
  11. ^ Goodrich RP, et al. “The Mirasol PRT System for Pathogen Reduction of Platelets and Plasma: An Overview of Current Status and Future Trends.” Transfusion and Apheresis Science 2006; 35 (1): 5-17.
  12. ^ Osselaer et al. "Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use". Transfusion 2009; 49:1412–1422.
  13. ^ Cazenave et al. "An active hemovigilance program characterizing the safety profile of 7,483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment". Transfusion 2010;50:1210–1219.
  14. ^ "Needle Exchange: A Primer". PBS. Retrieved October 18, 2017. 
  15. ^ Lurie, Peter (1993). The Public Health Impact of Needle Exchange Programs in the United States and Abroad (PDF). San Francisco, CA: UC Berkeley School of Public Health. 

External links[edit]